Harmony Biosciences Holdings Inc
HRMY · NASDAQ
Harmony Biosciences Holdings, Inc. operates as a pharmaceutical company. The Company focuses on the research, drug development, and treatment for neurologic disorder of sleep-wake state instability. Harmony Biosciences Holdings serves patients in the United States.
Market Data
Price
$34.18
-0.28 (-0.81%)
Market Cap$1.99B
P/E Ratio13.70
EPS$—
52W High$40.87
52W Low$25.52
Beta0.96
Data from Finnhub · Updated Jun 16, 2026